Thermo to Come out with ion trap/Fourier Transform Mass Spec Hybrid in March

During a presentation at last week’s JPMorgan 21st Annual Healthcare Conference, Thermo Electron, Thermo Finnigan’s parent company, announced that it will introduce an ion trap/FTMS hybrid at Pittcon in March.

The new instrument will have automated LC-MS/MS and MALDI-MS, offer high resolution (40,000 at 500 Da), and cost between $650,000 and $700,000.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

GenomeWeb Premium gives you:
✔ Full site access
✔ Interest-based email alerts
✔ Access to archives

Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In an against-all-odds twist, a researcher studying exceeding rare FOXG1 mutations discovers her daughter has the syndrome.

An effort by Genomics Medicine Ireland is creating a database of diseases based on the genomics of people in Ireland. It now is looking into the possibility of including Scotland in its work.

In recent weeks, the direct-to-consumer genetics firm has rolled out a health hub where customers can share information concerning 18 common health conditions.

In PLOS this week, new genes associated with prostate cancer risk, genetic patterns in M. bovis, and more.